Sexual response in patients treated with sacral neuromodulation for lower. van Voskuilen AC, Oerlemans DJ, Gielen N, Lansen-Koch SM, Weil EH, van

Transcription

1 Publicaties Dr. Ernest Weil: Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence. van Voskuilen AC, Oerlemans DJ, Gielen N, Lansen-Koch SM, Weil EH, van Lankveld JJ, van den Hombergh U, Baeten CG, van Kerrenbroeck PE. Urol Int. 2012;88(4): doi: / Epub 2012 Apr 26. PMID: Is on-demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime? Oerlemans DJ, van Voskuilen AC, Marcelissen T, Weil EH, de Bie RA, Van Neurourol Urodyn Nov;30(8): doi: /nau Epub 2011 Aug 8. PMID: Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida. Lansen-Koch SM, Govaert B, Oerlemans D, Melenhorst J, Vles H, Cornips E, Weil EH, van Heurn E, Baeten CG, van Gemert WG. Colorectal Dis Apr;14(4): doi: /j x. PMID: The impact of disadvantage on the development and progression of diabetic kidney disease. Weil EJ, Curtis JM, Hanson RL, Knowler WC, Nelson RG. Clin Nephrol Nov;74 Suppl 1:S32-8. Review. PMID:

2 Medium-term experience of sacral neuromodulation by tined lead implantation. Van Voskuilen AC, Oerlemans DJ, Weil EH, van den Hombergh U, van BJU Int Jan;99(1): Epub 2006 Sep 6. PMID: Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. van Voskuilen AC, Oerlemans DJ, Weil EH, de Bie RA, van Eur Urol Feb;49(2): Epub 2006 Jan 4. PMID: New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerdá JL, Kiss G, Heesakkers J. World J Urol Jul;23(3): Epub 2005 Jun 30. PMID: Ten years' experience in neuromodulation in maastricht. van Voskuilen AC, Weil EH, De Bie RA, van Kerrebroeck EV. Neuromodulation Jul;8(3): doi: /j x. No abstract available. PMID: Tined lead implantation: results of the first 37 implants in maastricht. van Voskuilen AC, Weil EH, van Kerrebroeck EV. Neuromodulation Jul;8(3): doi: /j x. PMID:

3 European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction. van Kerrebroeck EV, Scheepens WA, de Bie RA, Weil EH. Urol Clin North Am Feb;32(1):51-7. Review. PMID: Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder. Scheepens WA, van Koeveringe GA, de Bie RA, Weil EH, van Kerrebroeck PE. Eur Urol Mar;43(3): PMID: Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. Scheepens WA, Van Koeveringe GA, De Bie RA, Weil EH, Van Kerrebroeck PE. BJU Int Dec;90(9): PMID: Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. Scheepens WA, de Bie RA, Weil EH, van J Urol Nov;168(5): PMID: Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Scheepens WA, Jongen MM, Nieman FH, de Bie RA, Weil EH, van Urology Oct;60(4): PMID:

4 Novel test lead designs for sacral nerve stimulation: improved passive fixation in an animal model. Weil EH, Ruiz-Cerdá JL, van den Bogaard AE, van J Urol Aug;164(2): PMID: Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study. Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE. Eur Urol Oct;40(4): PMID: Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Weil EH, Ruiz-Cerdá JL, Eerdmans PH, Janknegt RA, Bemelmans BL, van Eur Urol Feb;37(2): PMID: Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. Weil EH, Ruiz-Cerdá JL, Eerdmans PH, Janknegt RA, Van World J Urol. 1998;16(5): PMID: Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. Weil EH, Eerdmans PH, Dijkman GA, Tamussino K, Feyereisl J, Vierhout ME, Schmidbauer C, Egarter C, Kölle D, Plasman JE, Heidler H, Abbühl BE, Wein W. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(3): PMID:

5 Efficacy of biofeedback, when included with pelvic floor muscle exercise treatment, for genuine stress incontinence. Berghmans LC, Frederiks CM, de Bie RA, Weil EH, Smeets LW, van Waalwijk van Doorn ES, Janknegt RA. Neurourol Urodyn. 1996;15(1): PMID: Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Dijkema HE, Weil EH, Mijs PT, Janknegt RA. Eur Urol. 1993;24(1):72-6. PMID: Transvaginal ultrasonography: a study with healthy volunteers and women with genuine stress incontinence. Weil EH, van Waalwijk van Doorn ES, Heesakkers JP, Meguid T, Janknegt RA. Eur Urol. 1993;24(2): PMID: Electrically stimulated gracilis sphincter for treatment of bladder sphincter incontinence. Janknegt RA, Baeten CG, Weil EH, Spaans F. Lancet Nov 7;340(8828): PMID:

6 [Initial experiences with neuromodulation as treatment for incontinence and micturition disorders in The Netherlands]. Dijkema HE, Weil EH, Janknegt RA. Ned Tijdschr Geneeskd Jan 11;136(2): Dutch. PMID: Left renal vein compression syndrome ("nutcracker phenomenon"). Stassen CM, Weil EH, Janevski BK. Rofo Jun;150(6): PMID: Bladder stones as an unusual cause of posttransplant macroscopic hematuria. Leunissen KM, Weil EH, Mooy JM, Ausems MM, Kootstra G, van Hooff JP. Transplantation Oct;44(4): No abstract available. PMID: Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer. Denis L, Keuppens F, Mahler C, Debruyne FM, Weil EH, Lunglmayr G, Newling D, Robinson MR, Richards B, Smith PH, et al. Prog Clin Biol Res. 1987;243A: No abstract available. PMID: [Treatment of advanced prostate carcinoma with a depot form of an LH- RH analog: preliminary endocrinological and clinical results]. Litjens TT, Fernandez del Moral P, van Laarhoven JP, Weil EH, Debruyne FM. Ned Tijdschr Geneeskd Apr 26;130(17): Dutch. No abstract available. PMID: Triamterene-induced nephrolithiasis. Ettinger B, Weil E, Mandel NS, Darling S. Ann Intern Med Nov;91(5): No abstract available. PMID:

7 Antegrade ureteroscopy: a new tool in management of severe ureteral strictures. de Jonge MK, van der Beek C, Weil EH, Coolsaet BL. Urology Jan;27(1): PMID: Can combined DES and LHRH depot therapy (ICI ) prevent endocrinologic and clinical flare-up in metastatic prostate cancer? Fernandez del Moral P, Litjens TT, Weil EH, Debruyne FM. Urology Aug;32(2): PMID: Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma. Debruyne FM, Denis L, Lunglmayer G, Mahler C, Newling DW, Richards B, Robinson MR, Smith PH, Weil EH, Whelan P. J Urol Oct;140(4): PMID: Electrically stimulated gracilis sphincter (dynamic graciloplasty) for treatment of intrinsic sphincter deficiency: a pilot study on feasibility and side effects. Janknegt RA, Heesakkers JP, Weil EH, Baeten CG. J Urol Nov;154(5): PMID: Thermotherapy and Hyperthermia Workshop. Laduc R, Weil EH, Zerbib M, Perrin P, Denis L. Prog Clin Biol Res. 1994;386: No abstract available. PMID: